CLINICAL_TRIALS
trial_result
· 2024-03-15
Clinical Trial Update: Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
Summary
A completed clinical trial comparing Spiolto Respimat (tiotropium/olodaterol) to triple therapy for COPD, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2024-03-15